Found 19 clinical trials
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
The disease promoted by coronavirus (COVID-19) is caused by Severe Acute Respiratory Syndrome (SARS) caused by Coronavirus type 2 (CoV2), being the first cases identified in December 2019 in China after exposure to the animal market in Wuhan city, China. From the first case to the present day, the COVID-19 …
- 0 views
- 27 Jan, 2021
- 1 location
Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence
This is a Phase II/III trial with two groups of adults successfully cured of category 1 pulmonary TB receiving either VPM1002 or placebo. Single dose of VPM1002 / placebo will be administered to calculate efficacy of the vaccine against TB recurrence.
- 58 views
- 24 Jan, 2021
- 10 locations
Measles and BCG Vaccines for Mother and Child
In Africa, the mortality from infectious diseases remains high. The investigators have discovered that live vaccines such as the BCG vaccine against tuberculosis and the measles vaccine can
- 0 views
- 03 Jun, 2021
- 1 location
BCG Vaccine for Health Care Workers as Defense Against COVID 19
SARS-CoV-2 spreads rapidly throughout the world. A large epidemic would seriously challenge the available hospital capacity, and this would be augmented by infection of healthcare workers (HCW). Strategies to prevent infection and disease severity of HCW are, therefore, desperately needed to safeguard continuous patient care. Bacille Calmette-Gurin (BCG) is a …
- 528 views
- 24 Jan, 2021
- 2 locations
Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
sufficient number of children are present for vaccination); or to offer additional BCG vaccines to make BCG available every day and open a vial of BCG if there is just one eligible child present. All
- 0 views
- 07 Mar, 2021
- 1 location
Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda
> Methods: This is an individually randomized clinical trial in 4,500 HIV exposed infants. The intervention is an intra-dermal administration of 0.05 ml of BCG vaccine within 24 hours of birth while the
- 19 views
- 24 Jan, 2021
- 1 location
COVID-19: BCG As Therapeutic Vaccine Transmission Limitation and Immunoglobulin Enhancement
To date, there is no vaccine or treatment with proven efficiency against COVID-19, and the transmissibility of the SARS-CoV-2 virus can be inferred by its identification in the oro-nasopharynx. The bacillus Calmette Gurin (BCG) has the potential for cross-protection against viral infections. This study evaluates the impact of previous (priming …
- 0 views
- 25 Jan, 2021
- 1 location
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
-Gurin (BCG) vaccine not only protects against tuberculosis, but also induces protection against various respiratory infections, including those with a viral etiology. We hypothesize that BCG
- 32 views
- 29 May, 2021
- 20 locations
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic
capital Bissau in Guinea-Bissau. Population: HCW (nurses/physicians/others) 18 years. Intervention: Block randomization 1:1 to intradermal standard dose (0.1 ml) of BCG vaccine or placebo (saline
- 0 views
- 27 Jan, 2021
- 3 locations
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic
years of age or above. Intervention: Participants will be randomized 1:1 to intradermal administration of a standard dose of BCG vaccine or placebo (saline). Outcomes: Primary outcome: "Acute
- 0 views
- 26 Jan, 2021
- 1 location
- 1
- 2